Located in one of the primary global hubs for the life sciences, healthcare, and technology industries, the Boston office of Arnold & Porter provides comprehensive and innovative services for clients ranging from early-stage startups and healthcare providers to multinational biopharmaceutical companies. Since the beginning of biotech decades ago, we have served a broad spectrum of Boston-based clients, managing their most critical and complex life sciences issues. With a focus on regulatory, litigation, and transactional services, the Boston office expands the capabilities of our globally-renowned life sciences practice and further integrates our firm’s market-leading interdisciplinary offerings into a dynamic region that is consistently at the forefront of innovation and change.
We advise clients on a wide variety of licensing matters from intellectual property assets that range from patent infringement and validity to trade secrets, trademarks, and copyrights. The team’s seasoned trial lawyers represent clients in matters involving commercial and product liability disputes; complex antitrust claims; class actions; consumer product pricing; misappropriation of trade secrets and proprietary information; alleged design and manufacturing defects; adequacy of product warnings; False Claim Act issues, state consumer protection act matters; contractual diligence obligations; and other related issues. Our extensive experience advising on digital health and technology deals, M&A and financings, licensing, collaborations, and commercial arrangements positions us to help life sciences companies and healthcare providers secure mission-critical results that enhance their ability to advance the standard for care in an ever-evolving, highly regulated industry.
Our multidisciplinary and highly respected team of Boston-based lawyers have deep local roots and are fully integrated into Arnold & Porter’s global client service platform. As we continue to grow the Boston office, we intend to build on the firm’s core strengths: from bet-the-company disputes in product liability, antitrust, and IP matters; to transformative deals and antitrust approvals; to defending clients in high-profile global regulatory and congressional investigations.